References
  1. Wang, D, Hu, B, Hu, C, Zhu, F, Liu, X, Zhang, J, Wang, B, Xiang, H, Cheng, Z, Xiong, Y, Zhao, Y, Li, Y, Wang, X, & Peng, Z. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323:1061-1069.
  2. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China. JAMA Cardiology 2020; 5(7) : 802-810.
  3. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 18s: 735-801.
  4. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020; 31: 1003-1008.
  5. Hu H, Ma F, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J 2020; https://doi.org/10.1093/eurheartj/ehaa190.
  6. Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, Harding CV, Hurwitz JL, Jeffery CC, Krahn AD, Kusumoto FM, Lampert R, Mansour M, Natale A, Patton KK, Seiler A, Shah MJ, Wang PJ, Russo AM. Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology. Heart Rhythm. 2020 Jun 12:S1547-5271(20)30554-3
  7. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19 arrhythmic risk and inflammation: mind the gap. Circulation 2020; 142: 7-9.
  8. Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK, Gopinathannair R, Biviano AB, Garan H, Wan EY. Cardiac arrhythmias in COVID-19 infection. Circ Arrhythm Electrophysiol 2020; 13(6).
  9. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease. JAMA Cardiol 2020. 5(7) :1-8.
  10. Verny C, de Gennes C, Sébastien P, Lê Thi HD, Chapelon C, Piette JC, Chomette G, Godeau P. Heart Conduction Disorders in Long-Term Treatment with Chloroquine. Two New Cases. Press Med. 1992; 21: 800-4.
  11. Capel RA, Herring N, Kalla M, Yavari A, Mirams GR, Douglas G, Bub G, Channon K, Paterson DJ, Terrar DA, Burton RA. Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: novel electrophysiological insights and therapeutic potential. Heart Rhythm 2015; 12: 2186-2194.
  12. Colon CM, barrios JG, Chiles JW, McElwee SK, Russel DW, Maddox WR, Kay GN. Atrial arrhythmias in COVID-19 patients. JACC Clinical electrophysiology 2020. Epublished DOI:10.1016/j.jacep.2020.05.015.
  13. Sala S, Peretto G, De Luca G, Farina N, Campochiaro C, Tresoldi M, Dagna L, Zangrillo A, Gulletta S, Della Bella P.  Low prevalence of arrhythmias in clinically stable COVID-19 patients. Pacing Clin Electrophysiol 2020; https://doi.org/10.1111/pace.13987
  14. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, Moss J, Chahal AA, Anesi G, Denduluri S, Domenico CM, Arkles J, Abella BS, Bullinga JR, Callans DJ, Dixit S, Epstein AE, Frankel DS, Garcia FC, Kumareswaram R, Nazarian S, Riley MP, Santangeli P, Schaller RD, Supple GE, Lin D, Marchlinski F, Deo R. COVID-19 and cardiac arrhythmias. Heart Rhythm 2020; 22 : S1547-5271.
  15. Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Kabra R, Natale A, Poe S, Saha SA, Russo AM. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interventional Cardiac Electrophysiol 2020; 3:1–8.
  16. Onder G, Rezza G, Brusaferro S. Case-fatality and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323: 1775-1776.
  17. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37:2129.
  18. Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B, Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2016; 18: 12–36.
  19. Chapman AR, Bularga A, Mills NL. High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation 2020.